
A life-threatening condition called serotonin syndrome can happen when medicines called selective serotonin reuptake inhibitors (SSRIs), such as Celexa®, and medicines used to treat migraine headaches known as “triptans” (e.g. sumatriptan/ Imitrex®) are used together. Signs and symptoms of serotonin syndrome may include: restlessness, hallucinations, loss of coordination, fast heart beat, increased body temperature, fast changes in blood pressure, overactive reflexes, diarrhea, nausea, vomiting and coma.
Serotonin syndrome may be more likely to occur when starting or increasing the dose of an SSRI or a triptan. Before you take Celexa® and a triptan together, talk to your healthcare professional. If you must take these medicines together, be aware of the possibility of serotonin syndrome, and get medical care right away if you think serotonin syndrome is happening to you.
This information reflects the FDA’s current analysis of data available to FDA concerning this drug
FDA ALERT [07/2006] – Infant Persistent Pulmonary Hypertension
The results of a study that looked at the use of antidepressant medicines during pregnancy in mothers of babies born with a serious condition called persistent pulmonary hypertension of the newborn (PPHN) was recently published in a medical journal. Babies born with PPHN have abnormal blood flow through the heart and lungs and do not get enough oxygen to their bodies. Babies with PPHN can be very sick and may die.
The study results showed that babies born to mothers who took selective serotonin reuptake inhibitors (SSRIs), the family of medicines Celexa® belongs to, 20 weeks or later in their pregnancies had a higher chance (were 6 times as likely) to have PPHN than babies born to mothers who did not take antidepressants during pregnancy (6-12 per 1000 births versus 1-2 per 1000 births).
The FDA plans to further look at the role of SSRIs in babies with PPHN. Talk to your doctor if you are taking Celexa® and are pregnant or are planning to have a baby. You and your doctor will need to talk about the best way to treat your depression during pregnancy.
This information reflects the FDA’s current analysis of data available to FDA concerning this drug
FDA ALERT [05/2007] - Suicidal Thoughts or Actions in Children and Adults
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications. This risk may persist until significant remission occurs.
In short-term studies, antidepressants increased the risk of suicidality in children, adolescents and young adults when compared to placebo. Taking antidepressants may increase suicidality in about 1 out of 50 people 18 years or younger. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24.
Patients, their families and caregivers should be alert to the emergence of anxiety, restlessness, irritability, aggressiveness and insomnia. If these symptoms emerge, they should be reported to the patient’s prescriber or health care professional. All patients being treated with antidepressants for any indication should watch for and notify their health care provider for worsening symptoms, suicidality and unusual changes in behavior, especially during the first few months of treatment.
This information reflects the FDA’s current analysis of data available to FDA concerning this drug.
Tablets: 10mg, 20mg, and 40mg
Liquid: 2mg per ml
Tablets: 10 mg, 20 mg, and 40 mg
Liquid: 2mg/mL
Citalopram is an antidepressant medication that works in the brain. It belongs to a class of medications known as a Selective Serotonin Reuptake Inhibitors (SSRIs). Citalopram is approved for the treatment of Major Depressive Disorder (MDD). Other SSRIs are FDA approved for various anxiety disorders (e.g. Generalized Anxiety Disorder, Panic Disorder, etc.), bulimia and premenstrual dysphoric disorder. While citalopram has not been approved for these disorders, it is commonly used to treat such conditions.
Major Depression occurs when a person experiences at least five symptoms of depression, one of which must be either sad or depressed mood, or loss of interest in most activities. Other symptoms include changes in sleep (usually poor sleep); changes in appetite (usually decreased); loss of energy; feeling worthless/guilty/ hopeless/ helpless; psychomotor agitation or retardation (i.e. thoughts/movements speeding up or slowing down); difficulty concentrating; and thoughts of death (suicidal thinking). These symptoms must be present for a minimum of two weeks to satisfy the diagnosis of MDD.
After starting citalopram, symptoms gradually decrease over a period of weeks. Sleep and other physical symptoms may improve before there is noticeable improvement in mood or interest in activities. Once symptoms are under control, MDD usually requires long-term treatment to help prevent the return of depressive symptoms. Only your healthcare provider can determine the length of citalopram treatment that is right for you.
Do not stop taking citalopram or change your dose without talking to with your healthcare provider first.
Stopping citalopram abruptly may result in one or more of the following withdrawal symptoms: irritability, nausea, dizziness, vomiting, nightmares, headache and paresthesias (prickling, tingling sensation on the skin).
Because depression is also a part of Bipolar illness, people who take antidepressants may be at risk for "switching" from depression into mania. Symptoms of mania include "high" or irritable mood, very high self esteem, decreased need for sleep, pressure to keep talking, racing thoughts, being easily distracted, or frequently involved in activities with a large risk for bad consequences (e.g. excessive buying sprees).
If you are pregnant or are planning to become pregnant, it is very important to discuss the risks and benefits of taking citalopram with your provider. The FDA has classified citalopram as Category C in regards to pregnancy risk. This means that there have not been well-controlled studies in humans examining safety or that animal studies have demonstrated adverse effects to the developing fetus.
The benefits of citalopram in pregnancy may still be greater than the potential risks. For instance, if depression is left untreated during pregnancy, there is a high risk for poor prenatal care and premature delivery, and the babies may exhibit developmental delays in speech, intelligence, and socialization skills. Women who stop their antidepressants after learning of a pregnancy are five times more likely to relapse than pregnant women who continue their antidepressant. Women who suffer with depression during their pregnancy are much more likely to become depressed postpartum as well.
As the risk for relapse or worsening depressive symptoms varies greatly among women during pregnancy, the decision to treat with antidepressants must be made on an individual basis. This decision is best made following thoughtful discussion with a trusted and informed health professional.
Regarding breast-feeding, it is believed that virtually all antidepressants (including citalopram) will pass into the breast milk. The concentrations in breast milk are generally quite low with citalopram, even at higher doses, and it would not be expected to cause adverse effects in babies. However, breastfeeding mothers should monitor their infants for behavioral side effects and adequate growth.
Citalopram is usually taken once daily with or without food. It may be taken in the morning with food to minimize upset stomach and insomnia
While the dose usually ranges from 10 mg to 60 mg, your healthcare provider will determine the dose that is right for you based upon your response.
If you miss a dose of citalopram, take it as soon as you remember unless it is close to when your next dose is due. If it is close to your next dose, wait until then to take the medication and skip the missed dose. Do not double your next dose or take more than your prescribed dose.
Avoid drinking alcohol or using illegal drugs while you are taking antidepressant medications because the beneficial effects of the medication may be decreased and adverse effects may be increased (e.g. sedation).
If an overdose occurs, whether intentional or accidental, immediate medical attention may be necessary. Call your doctor or emergency medical service (911). You may also contact the poison control center (1-800-222-1222).
Symptoms of overdose include drowsiness, nausea, vomiting, abdominal pain, tremor, slow heart rate, and seizures. A specific antidote does not exist.
Common: Side effects with citalopram are generally mild and are similar to those reported with other SSRI antidepressants. The most commonly reported side effects are nausea, dry mouth, headache, sleepiness, insomnia, increased sweating, diarrhea, shakiness, fatigue, stomach pain, yawning, flatulence, weight loss or gain, dizziness, and restlessness. If you experience side effects after starting citalopram they will often improve over the first week or two as you continue to take the medication. Sexual side effects such as problems with orgasm or ejaculatory delay may also occur, and often do not diminish over time.
Rare: Other side effects which occur infrequently with citalopram include increased heart rate, low blood pressure, increased salivation, irregular menstrual cycle, increased frequency of urination, changes in taste, increased liver enzymes, increased bleeding (e.g. gums may bleed more easily), low sodium blood levels (signs may include headache, weakness, difficulty concentrating and remembering), and teeth grinding.
To date, there are no known neurotoxic or permanent side effects associated with long term use of citalopram. It is a safe and effective medication when used as directed.
Citalopram should not be taken with or within two weeks of taking monoamine oxidase inhibitors (MAOIs). These include phenelzine (Nardil®), tranylcypromine (Parnate®), isocarboxazid (Marplan®) and selegiline (Emsam®).
Although rare, there is an increased risk of serotonin syndrome when citalopram is used with medications that increase serotonin activity such as other antidepressants; migraine medications called “triptans” (e.g. Imitrex®); the analgesics tramadol (Ultram®) or meperidine (Demerol®); and the antibiotic linezolid (Zyvox®).
Citalopram may increase serum concentrations of clozapine. Monitoring carefully for side effects is recommended.
Citalopram may increase concentration of tricyclic antidepressants such as desipramine and beta blockers such as metoprolol, Monitoring carefully for side effects is recommended.
Cimetidine (Tagamet®) may increase the concentration of citalopram. Monitoring carefully for side effects is recommended.
Patients receiving warfarin therapy should be carefully monitored when citalopram is initiated or discontinued. Changes in bloodwork as well as increased bleeding have been reported when citalopram is co-administered with warfarin (Coumadin®), aspirin or pain relievers known as “NSAIDS” (Non-Steroidal Anti-inflammatory Agents).
Always let your doctor know what other prescription, over-the-counter, and herbal medications you are taking.
Disturbances in sleep, energy, or appetite may show some improvement within the first 1-2 weeks and can be an important early signal that the medication is working. Other symptoms such as depressed mood or lack of interest in activities may take 4-6 weeks before improvement is evident.
Updated by Lisa M. Mican, Pharm.D., BCPP
(February 2009)
NAMI wishes to thank the College of Psychiatric and Neurologic Pharmacists for producing this fact sheet.
For more information please contact the pharmaceutical company listed below.
|
Forest Pharmaceuticals, Inc. |
13600 Shoreline Drive St. Louis, MO 63045 |
800-678-1605 |
Free or low-cost medications provided by pharmaceutical companies
Some pharmaceutical companies offer medication assistance programs to low-income individuals and families. These programs typically require a doctor’s consent and proof of financial status. They may also require that you have either no health insurance, or no prescription drug benefit through your health insurance. Please contact the pharmaceutical company directly for specific eligibility requirements and application information.
Celexa Rx Assistance Program: 1-800-851-0758
Copyright © 1996 - 2010 NAMI. All Rights Reserved.